Iroko Pharmaceuticals, LLC
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Iroko Pharmaceuticals, LLC
Trofinetide could be the first approved drug for Rett patients after hitting both co-primary endpoints in a Phase III trial, but high rates of diarrhea and vomiting raise questions.
Health And Wellness Industry News: Restoring Access Bill Introduced, Another Dietary Fiber Meets FDA Definition, More
Restoring Access to OTC bill introduced; West Virginia is 18th state to prohibit sales of DXM-containing cough suppressant to minors without a prescription; American Botanical Council presents Norman R. Farnsworth Excellence Award to Swiss pharmacist Otto Sticher; FDA adds another fiber to definition of dietary fiber; and Jarrow probiotics top ConsumerLab brand survey.
A slate of bills recently approved by the US House Energy and Commerce Health Subcommittee seek to give Medicare stroke beneficiaries better access to telemedicine, provide coverage of DNA-based prostate cancer tests, and make changes to CMS's competitive bidding program for durable medical equipment to ensure diabetic beneficiaries receive diabetes test strips.
Labdoor, which offers online sales of products in addition to publishing rankings within product categories based on its evaluations, declined to offer evidence for NAD's review of challenges by Jarrow Formulas.
- Drug Delivery
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- iCeutica, Inc.